✦ LIBER ✦

Rationale for and Methods of Superiority, Noninferiority, or Equivalence Designs in Orthopaedic, Controlled Trials

✍ Scribed by Patrick Vavken

Book ID: 107564132
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 334 KB
Volume: 469
Category: Article
ISSN: 0009-921X
DOI: 10.1007/s11999-011-1773-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for and study design of the su

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy

✍ H. J. Lambers Heerspink; M. J. Fowler; J. Volgi; A. T. Reutens; I. Klein; T. A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Protocols: Angiotensin receptor blockade

Protocols: Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)

✍ Else Charlotte Sandset; Gordon Murray; Gudrun Boysen; Dalius Jatuzis; Janika Kõr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Randomized, controlled, blinded trial of

Randomized, controlled, blinded trial of Tissucol/Tisseel for mesh fixation in patients undergoing Lichtenstein technique for primary inguinal hernia repair: rationale and study design of the TIMELI trial

✍ G. Campanelli; G. Champault; M. Hidalgo Pascual; A. Hoeferlin; A. Kingsnorth; J. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 291 KB

Rationale and Design of ATHENA: A Placeb

Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter

✍ STEFAN H. HOHNLOSER; STUART J. CONNOLLY; HARRY J.G.M. CRIJNS; RICHARD L. PAGE; W 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

POBASCAM, a population-based randomized

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

✍ Nicole W.J. Bulkmans; Lawrence Rozendaal; Peter J.F. Snijders; Feja J. Voorhorst 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB 👁 2 views

## Abstract Cytological cervical screening is rather inefficient because of relatively high proportions of false negative and false positive smears. To evaluate the efficiency of high‐risk human papillomavirus (hrHPV) testing, by GP5+/6+ PCR‐enzyme immunoassay (EIA), in conjunction with cytology (I

Randomized controlled trial of human pap

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

✍ Marie-Hélène Mayrand; Eliane Duarte-Franco; François Coutlée; Isabel Rodrigues; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 1 views

## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare